Tracking the ANRO option chain helps you see every strike and expiry on Alto Neuroscience Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Alto Neuroscience Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ANRO options activity at a glance. Use our scanner to monitor the ANRO option chain in real time and filter for the ANRO options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ANRO stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ANRO option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ANRO stock options are being actively traded and where they are not.
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the treatment of patients with major depressive disorder (MDD) and post-traumatic stress disorder; ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties to treat patients with MDD; and ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor for the treatment of cognitive impairment associated with schizophrenia. It also develops ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist to treat patients with MDD and higher levels of anhedonia, and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor for the treatment of MDD.
In addition, the company develops novel pharmacodynamically synergistic combinations and an AI-enabled biomarker platform that combine sources of information on patients brain activity and behavior to identify patients to respond to novel product candidates. Alto Neuroscience, Inc. was incorporated in 2019 and is based in Los Altos, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Alto Neuroscience Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ANRO options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ANRO stock options — let the full option chain come to you, pre-filtered and ready to trade.
